LTZ Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- LTZ Therapeutics's estimated annual revenue is currently $2.6M per year.
- LTZ Therapeutics's estimated revenue per employee is $77,500
- LTZ Therapeutics's total funding is $27M.
Employee Data
- LTZ Therapeutics has 33 Employees.
- LTZ Therapeutics grew their employee count by 38% last year.
LTZ Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is LTZ Therapeutics?
LTZ Therapeutics is an immunotherapy-focused biotech company to develop novel therapies to improve clinical outcomes in patients with cancer and other diseases with an unmet clinical need. With main operations in Palo Alto, California and Shenzhen China as well as a team out of Heidelberg Germany, LTZ is dedicated to developing immunotherapies capable of overcoming resistance and boosting anti-tumor immunity based on reverse translational science and emerging biology of tumor microenvironment.
keywords:N/A
$27M
Total Funding
33
Number of Employees
$2.6M
Revenue (est)
38%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Palo Alto
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $5.3M | 33 | 74% | $3.2M |
#2 | $3.8M | 33 | -3% | N/A |
#3 | $4.2M | 33 | 3% | N/A |
#4 | $5.1M | 33 | -15% | N/A |
#5 | $7.3M | 33 | -20% | N/A |